MedTrace Logo

Permian Health Women's Lung Health Study

NCT06029543 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2023-09-08

No results posted yet for this study

Summary

The goal of this cross-sectional observational study is to estimate the prevalence of lung function impairment as measured by spirometry in a population of Gambian women aged 15 and older. The main question\[s\] it aims to answer are:

* What is the prevalence of lung function impairment in Gambian women
* What is the prevalence of eosinophilic inflammation in Gambian women

Consenting participants will undergo

* Spirometry
* Fractional exhaled nitric oxide (FENO) testing
* α1-antitrypsin testing in patients with lung function impairment as assessed by spirometry

Conditions

  • COPD
  • Lung Function Decreased
  • Alpha 1-Antitrypsin

Sponsors & Collaborators

  • The Gambia Committee on Traditional Practices Affecting the Health of Women and Children (GAMCOTRAP)

    collaborator UNKNOWN

  • Permian Health Lung Institute

    lead OTHER

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • The Gambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06029543 on ClinicalTrials.gov